Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
A607893-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $36.90 | |
A607893-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $88.90 | |
A607893-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $149.90 | |
A607893-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $329.90 | |
A607893-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $557.90 |
Synonyms | AKOS030228502|n-(1-adamantylmethyl)-2-chloro-5-(3-(3-hydroxypropylamino)propyl)benzamide|HSQAARMBHJCUOK-UHFFFAOYSA-N|AC-36649|AZD-9056 free base|EX-A6120|F13K378W4L|BDBM50267791|UNII-F13K378W4L|2-Chloro-5-[3-[(3-hydroxypropyl)amino]propyl]-N-(tricyclo[3.3 |
---|---|
Specifications & Purity | 98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Product Description | AZD9056 hydrochloride is a selective orally active inhibitor of P2X7 which plays a significant role in inflammation and pain-causing diseases. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | N-(1-adamantylmethyl)-2-chloro-5-[3-(3-hydroxypropylamino)propyl]benzamide;hydrochloride |
---|---|
INCHI | InChI=1S/C24H35ClN2O2.ClH/c25-22-5-4-17(3-1-6-26-7-2-8-28)12-21(22)23(29)27-16-24-13-18-9-19(14-24)11-20(10-18)15-24;/h4-5,12,18-20,26,28H,1-3,6-11,13-16H2,(H,27,29);1H |
InChi Key | LZBBHFRRZLDHLE-UHFFFAOYSA-N |
Canonical SMILES | C1C2CC3CC1CC(C2)(C3)CNC(=O)C4=C(C=CC(=C4)CCCNCCCO)Cl.Cl |
Isomeric SMILES | C1C2CC3CC1CC(C2)(C3)CNC(=O)C4=C(C=CC(=C4)CCCNCCCO)Cl.Cl |
Alternate CAS | 345303-91-5 |
PubChem CID | 10161380 |
Molecular Weight | 455.46 |
PubChem CID | 10161381 |
---|---|
CAS Registry No. | 345304-65-6 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2417175 | Certificate of Analysis | Apr 09, 2024 | A607893 |
G2417176 | Certificate of Analysis | Apr 09, 2024 | A607893 |
G2417177 | Certificate of Analysis | Apr 09, 2024 | A607893 |
G2417181 | Certificate of Analysis | Apr 09, 2024 | A607893 |
G2417182 | Certificate of Analysis | Apr 09, 2024 | A607893 |
G2417185 | Certificate of Analysis | Apr 09, 2024 | A607893 |
G2417192 | Certificate of Analysis | Apr 09, 2024 | A607893 |
G2417193 | Certificate of Analysis | Apr 09, 2024 | A607893 |
G2417197 | Certificate of Analysis | Apr 09, 2024 | A607893 |
G2417206 | Certificate of Analysis | Apr 09, 2024 | A607893 |
Sensitivity | Moisture sensitive |
---|
1. McInnes IB, Cruwys S, Bowers K, Braddock M. (2014) Targeting the P2X7 receptor in rheumatoid arthritis: biological rationale for P2X7 antagonism.. Clin Exp Rheumatol, 32 (6): (878-82). [PMID:25288220] |